These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 22467241)

  • 1. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
    Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
    J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of Ac45 Simultaneously Inhibits Osteoclast-Mediated Bone Resorption and Attenuates Dendritic Cell-Mediated Inflammation through Impairing Acidification and Cathepsin K Secretion.
    Yang W; Zhu Z; Li L; McVicar A; Gao N; Wang L; Li YP; Chen W
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic terminus of vacuolar type proton pump accessory subunit Ac45 is required for proper interaction with V(0) domain subunits and efficient osteoclastic bone resorption.
    Feng H; Cheng T; Pavlos NJ; Yip KH; Carrello A; Seeber R; Eidne K; Zheng MH; Xu J
    J Biol Chem; 2008 May; 283(19):13194-204. PubMed ID: 18227071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.
    Wu H; Xu G; Li YP
    J Bone Miner Res; 2009 May; 24(5):871-85. PubMed ID: 19113919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatile roles of V-ATPases accessory subunit Ac45 in osteoclast formation and function.
    Qin A; Cheng TS; Lin Z; Pavlos NJ; Jiang Q; Xu J; Dai KR; Zheng MH
    PLoS One; 2011; 6(11):e27155. PubMed ID: 22087256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aesculetin Inhibits Osteoclastic Bone Resorption through Blocking Ruffled Border Formation and Lysosomal Trafficking.
    Na W; Lee EJ; Kang MK; Kim YH; Kim DY; Oh H; Kim SI; Oh SY; Kang YH
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts.
    Cremasco V; Decker CE; Stumpo D; Blackshear PJ; Nakayama KI; Nakayama K; Lupu TS; Graham DB; Novack DV; Faccio R
    J Bone Miner Res; 2012 Dec; 27(12):2452-63. PubMed ID: 22806935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.
    Feng S; Deng L; Chen W; Shao J; Xu G; Li YP
    Biochem J; 2009 Jan; 417(1):195-203. PubMed ID: 18657050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin-binding protein coronin 1A controls osteoclastic bone resorption by regulating lysosomal secretion of cathepsin K.
    Ohmae S; Noma N; Toyomoto M; Shinohara M; Takeiri M; Fuji H; Takemoto K; Iwaisako K; Fujita T; Takeda N; Kawatani M; Aoyama M; Hagiwara M; Ishihama Y; Asagiri M
    Sci Rep; 2017 Mar; 7():41710. PubMed ID: 28300073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V-ATPase a3 Subunit in Secretory Lysosome Trafficking in Osteoclasts.
    Nakanishi-Matsui M; Matsumoto N
    Biol Pharm Bull; 2022; 45(10):1426-1431. PubMed ID: 36184499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUFY4 deletion prevents pathological bone loss by blocking endo-lysosomal trafficking of osteoclasts.
    Kim M; Park JH; Go M; Lee N; Seo J; Lee H; Kim D; Ha H; Kim T; Jeong MS; Kim S; Kim T; Kim HS; Kang D; Shim H; Lee SY
    Bone Res; 2024 May; 12(1):29. PubMed ID: 38744829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis.
    Voronov I; Ochotny N; Jaumouillé V; Owen C; Manolson MF; Aubin JE
    J Bone Miner Res; 2013 Jan; 28(1):108-18. PubMed ID: 22865292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts.
    Sahara T; Itoh K; Debari K; Sasaki T
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb; 270(2):152-61. PubMed ID: 12524690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
    Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
    J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine affects bone resorption and suppresses the expression of cathepsin K, MMP-9 and vacuolar-type H(+)-ATPase d2 and actin organization in osteoclasts.
    Tanaka H; Tanabe N; Kawato T; Nakai K; Kariya T; Matsumoto S; Zhao N; Motohashi M; Maeno M
    PLoS One; 2013; 8(3):e59402. PubMed ID: 23555029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the dynein-dynactin complex unveils motor-specific functions in osteoclast formation and bone resorption.
    Ng PY; Cheng TS; Zhao H; Ye S; Sm Ang E; Khor EC; Feng HT; Xu J; Zheng MH; Pavlos NJ
    J Bone Miner Res; 2013 Jan; 28(1):119-34. PubMed ID: 22887640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of osteoclast bone resorption by disrupting vacuolar H+-ATPase a3-B2 subunit interaction.
    Kartner N; Yao Y; Li K; Crasto GJ; Datti A; Manolson MF
    J Biol Chem; 2010 Nov; 285(48):37476-90. PubMed ID: 20837476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional complementation of V-ATPase a subunit isoforms in osteoclasts.
    Matsumoto N; Sekiya M; Fujimoto Y; Haga S; Sun-Wada GH; Wada Y; Nakanishi-Matsui M
    J Biochem; 2021 Apr; 169(4):459-466. PubMed ID: 33135054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform.
    Nyman JK; Väänänen HK
    Calcif Tissue Int; 2010 Sep; 87(3):273-83. PubMed ID: 20596699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.